The report on the global pharmaceutical intermediates market provides qualitative and quantitative analysis for the period from 2016 to 2024.
The report predicts the global pharmaceutical intermediates market to grow with a CAGR of 4.20% over the forecast period from 2018-2024. The study on pharmaceutical intermediates market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.
The report on pharmaceutical intermediates market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global pharmaceutical intermediates market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings. Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global pharmaceutical intermediates market over the period of 2016 to 2024. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings 1) Drivers • Growing Incidences of Various Diseases Such as Chronic Diseases, infectious Diseases • Growing Geriartric Population • Rising Demand for Innovative and Targeted Therapies 2) Restraints • Strict Government Regulation Related to Pharmactical Industry 3) Opportunities • Rising Research and Development Activity Globally
A) Primary Research Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include 1. Key Opinion Leaders associated with Infinium Global Research 2. Internal and External subject matter experts 3. Professionals and participants from the industry
Our primary research respondents typically include 1. Executives working with leading companies in the market under review 2. Product/brand/marketing managers 3. CXO level executives 4. Regional/zonal/ country managers 5. Vice President level executives.
B) Secondary Research Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include 1. Company reports and publications 2. Government/institutional publications 3. Trade and associations journals 4. Databases such as WTO, OECD, World Bank, and among others. 5. Websites and publications by research agencies
Segment Covered The global pharmaceutical intermediates market is segmented on the basis of types, applications, and end-users.
The Global Pharmaceutical Intermediates Market by Types • GMP • Non GMP
The Global Pharmaceutical Intermediates Market by Applications • Vitamins • Antibiotics • Antipyretic Analgesics • Others
The Global Pharmaceutical Intermediates Market by End-Users • Pharmaceutical Companies • Research Labs • Contract Manufacturing Organizations • Others
What does this report deliver? 1. Comprehensive analysis of the global as well as regional markets of the pharmaceutical intermediates market. 2. Complete coverage of all the segments in the pharmaceutical intermediates market to analyze the trends, developments in the global market and forecast of market size up to 2024. 3. Comprehensive analysis of the companies operating in the global pharmaceutical intermediates market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company. 4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Our reports have been used by over 10K customers, including:
P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H2 2019 Summary According to the recently published report ’P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H2 2019’; P2X Purinoceptor 3 (P2RX3) pipeline Target constitutes close to 14 molecules. Out of which approximately 12 molecules are developed by...
Tumor Necrosis Factor Receptor Superfamily Member 5 - Pipeline Review, H2 2019 Summary Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) pipeline Target constitutes close to 25 molecules. Out of which approximately...
Integrin Beta 7 - Pipeline Review, H2 2019 Summary Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Integrin beta-7 is an integrin protein encoded by the ITGB7 gene. It interacts with the cell surface adhesion molecules MADCAM1 which is normally expressed by the vascular endothelium...
Big Pharma Licensing Trends, 2012–18 Big Pharma deal-making volume and value peaked in 2015, and fell slightly in 2016–18 Between 2014 and 2018, Big Pharma companies signed a total of more than 1,450 drug-focused deals, growing at a compound annual growth rate of 3%. Deal volume jumped 24% from 2014 to 2015, but dropped 6% in 2016, and...
247 pages •
By Asia Market Information & Development Company
• Oct 2019
China’s demand for Incretion Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.